Description

Triglimisave-1TAB is a medicine that contains a combination of Glimepiride and Pioglitazone. Glimepiride belongs to a class of drugs known as sulfonylureas and is used to treat type 2 diabetes mellitus. It helps to lower blood sugar levels by stimulating the release of insulin from the pancreas. Pioglitazone, on the other hand, is a thiazolidinedione that helps to improve insulin sensitivity in the body. This, in turn, helps to regulate blood sugar levels in individuals with type 2 diabetes. Triglimisave-1TAB is prescribed for individuals who are unable to control their blood sugar levels effectively with a single medication. The combination of Glimepiride and Pioglitazone provides a synergistic effect, enhancing the overall effectiveness of the treatment. The dosage and duration of use may vary depending on the individual’s condition and response to treatment.

Additional information